Central and peripheral adrenergic blocking actions of LSD and BOL.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001933:Brain Stem / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects*; D003042:Cocaine / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D007031:Hypothalamus / Q000187:drug effects; D066298:In Vitro Techniques; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010525:Peripheral Nerves / Q000187:drug effects*; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D013565:Sympatholytics / Q000494:pharmacology*; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D013565:Sympatholytics; D014662:Vasoconstrictor Agents; D008238:Lysergic Acid Diethylamide; D000242:Cyclic AMP; D003042:Cocaine; D009638:Norepinephrine